Depression Clinical Trials

A listing of Depression medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 156 clinical trials
featured
Clinical Trial of BI 425809 Effect on Cognition and Functional Capacity in Schizophrenia.

The objective of the study is to investigate the efficacy, safety and pharmacokinetics of four different doses of BI 425809 once daily compared to placebo given for 12 weeks in patients with schizophrenia on stable antipsychotic treatment.  

  • 19 views
  • 23 Nov, 2020
  • 1 location
featured
A Study to Evaluate the Safety and Efficacy of BIIB104 in Participants With Cognitive Impairment Associated With Schizophrenia (CIAS).

A Study to Evaluate the Safety and Efficacy of BIIB104 in Participants With Cognitive Impairment Associated With Schizophrenia (CIAS).  

major depressive disorder
depressed
depression
major depressive episode
  • 40 views
  • 22 Dec, 2020
  • 1 location
featured
A Two-Part Study of CLE-100 as an Adjunct Therapy in Subjects With Major Depressive Disorder

The pharmaceutical company Clexio is studying an investigational drug called CLE-100 and its effectiveness in treatment of major depressive disorder (MDD) symptoms. This Study has two parts

  • 2 views
  • 05 Apr, 2021
  • 1 location
featured
A Phase 2a, Randomized, Placebo-Controlled Clinical Study to Evaluate the Efficacy and Safety of MK-1942 Added to Stable Antidepressant Therapy in Participants With Treatment-Resistant Depression

Merck Sharp & Dohme Corp. is conducting this trial to test the investigational drug MK-1942 in people with treatment-resistant depression. The purpose of this trial is to test the safety

  • 0 views
  • 06 Apr, 2021
  • 1 location
featured
  • 56 views
  • 23 Nov, 2020
  • 1 location
featured
An Efficacy and Safety Study of Sirukumab in Participants With Major Depressive Disorder

An Efficacy and Safety Study of Sirukumab in Participants With Major Depressive Disorder

  • 394 views
  • 23 Nov, 2020
  • 1 location
featured
Study of Efficacy of PEAR-004 in Schizophrenia.

The purpose of the study is to determine in patients currently being administered antipsychotic pharmacotherapy whether PEAR-004 can further reduce symptoms of schizophrenia as measured by the Positive and Negative Syndrome Scale (PANSS). The overall rationale for the study is to assess the first prescription digital therapeutic (PDT) in schizophrenia …

schizophrenia
schizophrenia disorders
  • 32 views
  • 22 Dec, 2020
  • 1 location
featured
A Study to Evaluate the Effects of Basmisanil in Participants With Cognitive Impairment Associated With Schizophrenia (CIAS) Treated With Antipsychotics.

This multicenter study will assess the effects of 24 weeks of basmisanil treatment on cognition and functioning of stable schizophrenia participants treated with antipsychotics.  

antipsychotics
schizophrenia disorders
  • 33 views
  • 22 Dec, 2020
  • 1 location
featured
Evaluate TV-46000 as Maintenance Treatment in Adult and Adolescent Patients With Schizophrenia (RISE).

The purpose of the study is to evaluate the efficacy, safety, and tolerability of different dose regimens of TV-46000 administered subcutaneously as compared to placebo during maintenance treatment in adult and adolescent patients with schizophrenia. The study will include male and female patients, 13 to 65 years of age, who …

schizoaffective disorder
schizophrenia
risperidone
schizophrenia disorders
  • 25 views
  • 22 Dec, 2020
  • 1 location
featured
A Placebo-controlled, Double-blind, Parallel-group, Bayesian Adaptive Randomization Design and Dose Regimen-finding Study to Evaluate Safety, Tolerability and Efficacy of BAN2401 in Subjects With Early Alzheimer's Disease

A Placebo-controlled, Double-blind, Parallel-group, Bayesian Adaptive Randomization Design and Dose Regimen-finding Study to Evaluate Safety, Tolerability and Efficacy of BAN2401 in Subjects With Early Alzheimer's Disease

  • 146 views
  • 08 Dec, 2020
  • 1 location